Vivos Therapeutics gets FDA clearance for sleep apnea treatment device

Medical technology company Vivos Therapeutics received FDA 510(k) clearance for its daytime-nighttime device to treat obstructive sleep apnea.

Advertisement

Vivos Therapeutics develops treatments for dentofacial abnormalities, mild-to-moderate obstructive sleep apnea and snoring in adults.

The device expands the palate to open the airway and facilitate nasal breathing, according to a Jan. 4 news release. It is Vivos’ longest standing appliance and is used most among its trained dentists. The device can also be used in conjunction with other treatment modalities.

At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.

Advertisement

Next Up in Dental Technology

Advertisement

Comments are closed.